Technical Analysis for WINT - Windtree Therapeutic

Grade Last Price % Change Price Change
grade C 3.8 -7.32% -0.3000
WINT closed down 7.32 percent on Friday, February 21, 2020, on 45 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Down Down
Historical WINT trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish -7.32%
Golden Cross Bullish -7.32%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -7.32%
Narrow Range Bar Range Contraction -7.32%
200 DMA Support Bullish -7.32%
Older signals for WINT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Windtree Therapeutics, Inc., a biotechnology company, focuses on developing surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform includes a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and drug-delivery technologies being developed to enable the noninvasive administration of aerosolized KL4 surfactant. The company's lead development program comprises AEROSURF, a drug/device product that has completed Phase IIb clinical trial to treat respiratory distress syndrome in premature infants. It is also developing other aerosolized KL4 surfactant products. Windtree Therapeutics, Inc. has a strategic collaboration with Eleison Pharmaceuticals, Inc. for using its proprietary aerosol delivery system to deliver inhaled lipid cisplatin in combination with KL4 surfactant. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.
Medicine Biotechnology Medical Specialties Branches Of Biology Respiratory Diseases Drug Delivery Technologies Potential Applications Respiratory Physiology Neonatology

Is WINT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 5.35
52 Week Low 2.04
Average Volume 1,549
200-Day Moving Average 3.8189
50-Day Moving Average 3.8464
20-Day Moving Average 4.0555
10-Day Moving Average 4.0180
Average True Range 0.3812
ADX 29.86
+DI 14.0346
-DI 45.7338
Chandelier Exit (Long, 3 ATRs ) 3.3064
Chandelier Exit (Short, 3 ATRs ) 4.5236
Upper Bollinger Band 4.5373
Lower Bollinger Band 3.5737
Percent B (%b) 0.23
BandWidth 23.7603
MACD Line 0.0329
MACD Signal Line 0.0681
MACD Histogram -0.0352
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.0850
Resistance 3 (R3) 4.0533 3.9267 4.0375
Resistance 2 (R2) 3.9267 3.8541 3.9425 4.0217
Resistance 1 (R1) 3.8633 3.8092 3.8950 3.8950 4.0058
Pivot Point 3.7367 3.7367 3.7525 3.7525 3.7367
Support 1 (S1) 3.6733 3.6641 3.7050 3.7050 3.5942
Support 2 (S2) 3.5467 3.6192 3.5625 3.5783
Support 3 (S3) 3.4833 3.5467 3.5625
Support 4 (S4) 3.5150